Successful intra-arterial thrombolysis in a patient with an intracranial meningioma.

Abstract

Alteplase (recombinant tissue plasminogen activator [rt-PA]) label approval by the Food and Drug Administration remarks the contraindication of its use with known intracranial neoplasm because of potential bleeding complications. Despite this concern, the real risk of intracerebral bleeding in patients with intracranial neoplasms treated with rt-PA is… (More)
DOI: 10.1016/j.jstrokecerebrovasdis.2013.05.009

Topics

Cite this paper

@article{Baiense2013SuccessfulIT, title={Successful intra-arterial thrombolysis in a patient with an intracranial meningioma.}, author={Robson Fantinato Baiense and Agessandro Abrah{\~a}o and Irapu{\'a} Ferreira Ricarte and Thiago Gonçalves Fukuda and Ricardo T. A. de Oliveira and Gisele S Seixas da Silva and Maristela Carvalho Costa and Manoel J. Teixeira}, journal={Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association}, year={2013}, volume={22 8}, pages={e658-60} }